Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bile Duct Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05738057
What this trial is testing

Combined Therapy Using D-TACE, Gemcitabine and Cisplatin, and PD1 Antibody in Advanced and Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Unresectable Intrahepatic Cholangiocarcinoma
Hua Li 22
Early research (Phase 1)Looking for participantsNCT06043466
What this trial is testing

A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors

Who this might be right for
Colorectal CancerEsophagus CancerGastric Cancer+4 more
Chongqing Precision Biotech Co., Ltd 30
Not applicableStudy completedNCT01844245
What this trial is testing

Endobiliary RFA for Unresectable Malignant Biliary Strictures

Who this might be right for
CholangiocarcinomaAmpullary Carcinoma
Bing Hu 174
Testing effectiveness (Phase 2)Study completedNCT03693807
What this trial is testing

The Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma

Who this might be right for
Colorectal CancerCholangiocarcinoma
Memorial Sloan Kettering Cancer Center 35
Testing effectiveness (Phase 2)Looking for participantsNCT05732831
What this trial is testing

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

Who this might be right for
Locally Advanced Solid Tumor
Tango Therapeutics, Inc. 225
Testing effectiveness (Phase 2)UnknownNCT05400902
What this trial is testing

HAIC Combined With Sintilimab and Bevacizumab for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Binkui Li 17
Not applicableLooking for participantsNCT05714124
What this trial is testing

Liver Embolization Approaches for Tumor Management

Who this might be right for
Hepatocellular CarcinomaCholangiocarcinomaMetastatic Colon Cancer+4 more
IRCCS San Raffaele 580
Large-scale testing (Phase 3)WithdrawnNCT00253617
What this trial is testing

Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery

Who this might be right for
Cholangiocarcinoma of the Extrahepatic Bile DuctCholangiocarcinoma of the GallbladderUnresectable Extrahepatic Bile Duct Cancer+3 more
Jonsson Comprehensive Cancer Center
Not applicableActive Not RecruitingNCT02757859
What this trial is testing

WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer

Who this might be right for
Acinar Cell CarcinomaAmpulla of Vater AdenocarcinomaCholangiocarcinoma+5 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 845
Large-scale testing (Phase 3)Active Not RecruitingNCT02482454
What this trial is testing

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
The First People's Hospital of Changzhou 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07160283
What this trial is testing

The Efficacy and Safety of Trilaciclib in Bone Marrow Protection Before Chemotherapy for Advanced Bile Duct Cancer and Pancreatic Cancer

Who this might be right for
Biliary Tract NeoplasmsPancreatic Neoplasms
The Second Affiliated Hospital of Shandong First Medical University 96
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Ended earlyNCT00959946
What this trial is testing

Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer

Who this might be right for
Advanced Breast Cancer (Parts 1 and 2)Advanced Pancreatic Cancer (Part 1)Advanced Colorectal Cancer (Part 1)+2 more
Pfizer 32
Not applicableApproved For MarketingNCT04507503
What this trial is testing

Expanded Access Study of TAS-120 in Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements

Who this might be right for
Advanced Cholangiocarcinoma
Taiho Oncology, Inc.
Testing effectiveness (Phase 2)Study completedNCT01320254
What this trial is testing

PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine)

Who this might be right for
Cholangiocarcinomas
Hannover Medical School 93
Not applicableUnknownNCT04318834
What this trial is testing

Molecular Profiling of Advanced Biliary Tract Cancers

Who this might be right for
Biliary Tract Cancer
McGill University Health Centre/Research Institute of the McGill University Health Centre 40
Not applicableUnknownNCT01686425
What this trial is testing

Percutaneous Transhepatic Cholangiography Versus Endoscopic Ultrasound Guided Biliary Drainage

Who this might be right for
Malignant Biliary Obstruction
Universitaire Ziekenhuizen KU Leuven 60
Not applicableStudy completedNCT07483242
What this trial is testing

Individualized Surgical Guidance in HCC-BDTT

Who this might be right for
Hepatocellular Carcinoma (HCC)
First Affiliated Hospital, Sun Yat-Sen University 151
Not applicableEnded earlyNCT00753441
What this trial is testing

Endoscopic Stenting Versus Surgical Bypass for Low Bile Duct Obstruction by Cancer of the Pancreatic Head

Who this might be right for
Pancreatic Cancer
Heidelberg University 24
Testing effectiveness (Phase 2)Looking for participantsNCT06503146
What this trial is testing

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

Who this might be right for
SarcomaSmall Cell Lung Cancer or Extrapulmonary Neuroendocrine Cancer (EP-NEC)Mesothelioma+7 more
National Cancer Institute (NCI) 320
Next Page